🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was intended to evaluate the efficacy, safety and tolerability o...
Status
Terminated
Location
Research Site
Start Date
2008-06
Trial ID
NCT00624468
Treatments Being Tested
This study is to evaluate the efficacy and safety of atacicept compared to ...
Status
Completed
Location
Division of Clinical Immunology and Rheumatology - UAB
Start Date
2008-01
Trial ID
NCT00624338
Treatments Being Tested
To evaluate the safety and tolerability of atacicept and to explore if atac...
Status
Terminated
Location
Research Site
Start Date
2008-04
Trial ID
NCT00642902
Treatments Being Tested
This is a multi-center, double-blind, randomized, Phase 2b trial to evaluat...
Status
Completed
Location
Pinnacle Research Group LLC
Start Date
2013-12
Trial ID
NCT01972568
Treatments Being Tested
Systemic lupus erythematosis (SLE) is an autoimmune disease, meaning that t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-02
Trial ID
NCT01440231
The objective of the study is to evaluate the effect of atacicept compared ...
Status
Withdrawn
Location
Vera Site # 0139
Start Date
2022-11-02
Trial ID
NCT05609812
The primary objective of this study is to evaluate the efficacy of atacicep...
Status
Completed
Location
Please Contact US Medical Information
Start Date
2007-09
Trial ID
NCT00595413
Treatments Being Tested
The primary objective of this study is to assess the safety and tolerabilit...
Status
Completed
Location
Research Site
Start Date
2008-03
Trial ID
NCT00664521
Treatments Being Tested
This main purpose of this study was to evaluate the safety, tolerability, d...
Status
Terminated
Location
AKDHC Medical Research Services, LLC.
Start Date
2017-01-31
Trial ID
NCT02808429
Treatments Being Tested
A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3)...
Status
Active Not Recruiting
Location
ORIGIN 3 Global Site Contact Information
Start Date
2023-06-29
Trial ID
NCT04716231
Treatments Being Tested